Understanding how tau protein affects brain degeneration in Alzheimer's disease using advanced imaging techniques
Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imaging
This study is looking at how the buildup of tau protein in the brain affects the damage caused by Alzheimer's disease, using special imaging techniques to help us understand the disease better and find ways to tailor treatments for different people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11019688 on NIH RePORTER |
What this research studies
This research investigates the relationship between tau protein accumulation and neurodegeneration in Alzheimer's disease through advanced imaging methods. By utilizing tau-PET imaging and structural MRI, the study aims to quantify how variations in tau levels correlate with brain atrophy in individuals with Alzheimer's. The researchers will analyze these relationships to identify different phenotypes of the disease, potentially leading to more personalized treatment approaches. This work seeks to enhance our understanding of Alzheimer's pathology and improve diagnostic accuracy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who exhibit symptoms and have measurable tau pathology.
Not a fit: Patients without a diagnosis of Alzheimer's disease or those who do not exhibit tau pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding tau pathology and its implications in Alzheimer's disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Das, Sandhitsu — University of Pennsylvania
- Study coordinator: Das, Sandhitsu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.